MetaMe Health is a telemedicine and microbiome company headquartered in Chicago, Illinois that was founded by Danny Bernstein in 2015. MetaMe Health offers a prescription-based digital brain-gut therapy called Regulora that is the first FDA approved digital treatment for Irritable Bowel Syndrome (IBS). MetaMe has completed over 25 randomized clinical trials that prove Regulora to be an effective treatment for reducing IBS symptoms. MetaMe Health is also developing a drug candidate for the treatment of heartburn.
Irritable bowel syndrome
Paul Enck, Qasim Aziz, Giovanni Barbara, Adam D Farmer, Shin Fukudo, Emeran A Mayer, Beate Niesler, Eamonn M M Quigley, Mirjana Rajilić-Stojanović, Michael Schemann, Juliane Schwille-Kiuntke, Magnus Simren, Stephan Zipfel, Robin C Spiller